v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (20,322) $ (36,210)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 270 259
Accretion and amortization on investments, net (1,777) (3,948)
Amortization of debt issuance costs/debt discounts 584 515
Non-cash interest expense on liabilities for sales of future royalties 7,776 9,880
Inventory write-off 6,329 0
Stock-based compensation expense 9,862 14,187
Amortization of right-of-use assets 388 358
Allowance for doubtful accounts increase/(decrease) (821) 21
Changes in assets and liabilities:    
Inventory (13,298) (30,410)
Accounts receivable, net (13,832) (684)
Prepaid expenses and other assets (1,260) (1,173)
Accounts payable (2,452) (369)
Accrued compensation and benefits (21,391) (11,471)
Accrued liabilities (20,624) (9,256)
Payments on royalty agreement (7,733) (6,705)
Operating lease liabilities (432) (388)
Net cash used in operating activities (78,733) (75,394)
Cash flows from investing activities:    
Purchases of property and equipment (475) (138)
Purchases of marketable securities (123,423) (123,173)
Proceeds from maturities and sales of marketable securities 184,049 196,065
Net cash provided by investing activities 60,151 72,754
Cash flows from financing activities:    
Proceeds from issuances of common stock from equity plans 1,984 847
Proceeds from the exercise of warrants 1,511 0
Proceeds from employee stock purchase plan 314 500
Net cash provided by financing activities 3,809 1,347
Net effect of exchange rates on cash, cash equivalents and restricted cash (136) 21
Net decrease in cash, cash equivalents and restricted cash (14,909) (1,272)
Cash, cash equivalents and restricted cash at the beginning of the period 79,440 80,876
Cash, cash equivalents and restricted cash at the end of the period $ 64,531 $ 79,604